184 related articles for article (PubMed ID: 6549599)
1. In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.
Reading CL; Kraemer PM; Miner KM; Nicolson GL
Clin Exp Metastasis; 1983; 1(2):135-51. PubMed ID: 6549599
[TBL] [Abstract][Full Text] [Related]
2. Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.
Miner KM; Nicolson GL
Cancer Res; 1983 May; 43(5):2063-7. PubMed ID: 6687559
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cell-cell adhesion molecules in liver colonization by metastatic murine lymphoma/lymphosarcoma variants.
McGuire EJ; Mascali JJ; Grady SR; Nicolson GL
Clin Exp Metastasis; 1984; 2(3):213-22. PubMed ID: 6549550
[TBL] [Abstract][Full Text] [Related]
4. Modification of cell surface glycoproteins, macrophage cytostasis, and blood-borne metastatic properties of the murine RAW117 large cell lymphoma by virus superinfection.
Yoshida M; Gallick GE; Irimura T; Nicolson GL
Cancer Res; 1987 May; 47(10):2558-62. PubMed ID: 3567891
[TBL] [Abstract][Full Text] [Related]
5. Sialoglycoproteins of murine RAW117 large cell lymphoma/lymphosarcoma sublines of various metastatic colonization properties.
Irimura T; Tressler RJ; Nicolson GL
Exp Cell Res; 1986 Aug; 165(2):403-16. PubMed ID: 3755104
[TBL] [Abstract][Full Text] [Related]
6. Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-gamma modulates the metastatic potential of murine RAW117 large-cell lymphoma cells.
LaBiche RA; Tressler RJ; Nicolson GL
Clin Exp Metastasis; 1993 Nov; 11(6):472-81. PubMed ID: 8222395
[TBL] [Abstract][Full Text] [Related]
7. Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma.
LaBiche RA; Yoshida M; Gallick GE; Irimura T; Robberson DL; Klostergaard J; Nicolson GL
J Cell Biochem; 1988 Apr; 36(4):393-403. PubMed ID: 3379107
[TBL] [Abstract][Full Text] [Related]
8. Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.
Joshi SS; Sharp JG; Brunson KW
Oncology; 1987; 44(3):180-5. PubMed ID: 3601320
[TBL] [Abstract][Full Text] [Related]
9. Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells.
Joshi SS; Sinangil F; Sharp JG; Mathews NB; Volsky DJ; Brunson KW
Cancer Detect Prev; 1988; 11(3-6):405-17. PubMed ID: 3390859
[TBL] [Abstract][Full Text] [Related]
10. Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.
Reading CL; Brunson KW; Torrianni M; Nicolson GL
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5943-7. PubMed ID: 6934525
[TBL] [Abstract][Full Text] [Related]
11. Adhesive, invasive, and growth properties of selected metastatic variants of a murine large-cell lymphoma.
Nicolson GL; Belloni PN; Tressler RJ; Dulski K; Inoue T; Cavanaugh PG
Invasion Metastasis; 1989; 9(2):102-16. PubMed ID: 2708004
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells.
Joshi SS; O'Connor SJ; Weisenburger DD; Sharp JG; Gharpure HM; Brunson KW
Clin Exp Metastasis; 1991; 9(1):27-37. PubMed ID: 2015714
[TBL] [Abstract][Full Text] [Related]
13. Selection and biologic properties of malignant variants of a murine lymphosarcoma.
Brunson KW; Nicolson GL
J Natl Cancer Inst; 1978 Dec; 61(6):1499-503. PubMed ID: 281557
[TBL] [Abstract][Full Text] [Related]
14. Cell surface properties associated with malignancy of metastatic large cell lymphoma cells.
Joshi SS; Tilden PA; Jackson JD; Sharp JG; Brunson KW
Cancer Res; 1987 Jul; 47(13):3551-7. PubMed ID: 3581088
[TBL] [Abstract][Full Text] [Related]
15. Differential growth properties of metastatic large-cell lymphoma cells in target organ-conditioned medium.
Nicolson GL
Exp Cell Res; 1987 Feb; 168(2):572-7. PubMed ID: 3803456
[TBL] [Abstract][Full Text] [Related]
16. Characterization of metastasis-associated antigens on RAW117 lymphosarcoma cell lines.
Joshi SS; Sharp JG; Gharpure HM; Brunson KW
Clin Exp Metastasis; 1987; 5(1):89-104. PubMed ID: 3103962
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility of metastatic lymphoma cells to natural immunity.
Hao WM; Joshi SS
Oncology; 1990; 47(6):483-7. PubMed ID: 2123024
[TBL] [Abstract][Full Text] [Related]
18. Modulating the metastatic potential of murine RAW117 large-cell lymphoma cells by selection for resistance to interferon-gamma.
LaBiche RA; Nicolson GL
Int J Cancer; 1993 Jul; 54(6):1002-9. PubMed ID: 8335393
[TBL] [Abstract][Full Text] [Related]
19. Enhanced immunosuppressive activity associated with metastatic lymphoma cells.
Hao W; McDonald TL; Brunson KW; Joshi SS
Cancer Res; 1993 Apr; 53(8):1921-8. PubMed ID: 8385575
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.
Joshi SS; Messbarger LJ; Hao W
Clin Exp Metastasis; 1994 Jan; 12(1):37-46. PubMed ID: 8287619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
